Gabelli Funds LLC Neuronetics, Inc. Transaction History

Gabelli Funds LLC

$12.6 Billion
Q1 2024

A detailed history of Gabelli Funds LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Gabelli Funds LLC holds 25,500 shares of STIM stock, worth $44,625. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,500

Previous 25,500 -0.0%

Holding current value

$44,625

Previous $73,000 65.75%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.05 - $2.9 $45,962 - $126,944	-43,774 Reduced 63.19%	25,500 $73,000
Q3 2023 Nov 08, 2023	SELL	$1.29 - $2.22 $173,121 - $297,930	-134,203 Reduced 65.95%	69,274 $93,000
Q2 2023 Aug 10, 2023	SELL	$2.07 - $2.92 $14,489 - $20,440	-7,000 Reduced 3.33%	203,477 $437,000
Q1 2023 May 12, 2023	SELL	$2.81 - $6.71 $8,430 - $20,130	-3,000 Reduced 1.41%	210,477 $612,000
Q4 2022 Feb 13, 2023	SELL	$3.44 - $6.87 $101,136 - $201,978	-29,400 Reduced 12.1%	213,477 $1.47 Million

Q3 2022 Nov 10, 2022	SELL	$2.35 - $4.66 $55,225 - $109,510	-23,500 Reduced 8.82%	242,877 $772,000
Q2 2022 Aug 12, 2022	BUY	$2.09 - $3.71 $25,707 - $45,633	12,300 Added 4.84%	266,377 $855,000
Q1 2022 May 13, 2022	BUY	$2.84 - $4.52 $23,288 - $37,064	8,200 Added 3.34%	254,077 $770,000
Q4 2021 Feb 11, 2022	BUY	$3.87 - $6.59 $114,497 - $194,971	29,586 Added 13.68%	245,877 $1.1 Million
Q3 2021 Nov 12, 2021	BUY	$6.22 - $15.54 $447,516 - $1.12 Million	71,948 Added 49.85%	216,291 $1.42 Million
Q2 2021 Aug 13, 2021	BUY	$10.15 - $17.25 $60,889 - $103,482	5,999 Added 4.34%	144,343 $2.31 Million
Q1 2021 May 14, 2021	BUY	$10.6 - $21.27 $808,769 - $1.62 Million	76,299 Added 122.97%	138,344 $1.71 Million
Q3 2020 Nov 06, 2020	BUY	$1.82 - $5.87 $77,431 - $249,739	42,545 Added 218.18%	62,045 $302,000
Q4 2019 Feb 14, 2020	BUY	$4.03 - $9.22 $78,585 - $179,790	19,500 New	19,500 $88,000

Others Institutions Holding STIM

# of Institutions

Shares Held

18.4M

Call Options Held

200

Put Options Held

3.6K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $47.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Neuronetics, Inc. Transaction History